Levetiracetam 87063-0192-12
- Manufacturer
- Asclemed Usa Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA091491
Need to source Levetiracetam? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Levetiracetam | 750 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
87063-0192-12Selected120 TABLET in 1 BOTTLE (87063-192-12)
Other packages for this product(3)
30 TABLET in 1 BOTTLE (87063-192-30)
60 TABLET in 1 BOTTLE (87063-192-60)
90 TABLET in 1 BOTTLE (87063-192-90)